[Caffeine-Free Functional Support] Get wellness and energy support without jitters or crashes
Critical adjustment period Early months require guidance for dosing, tolerance, & progress for long-term success 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more
As of February 28, 2024, Novo Nordisks share price had risen by over 70% in the previous year [see Figure 3], with its market cap in September briefly surpassing Denmarks annual GDP
The FDA is currently reviewing a decision from 2023 by Biden administration that restricted compounding certain peptides because there werent enough human safety studies
2024 doi: 10.1016/j.ajog.2024.08.024
10.1111/dom.12354 12 BauerP